Previous Page  11 / 17 Next Page
Information
Show Menu
Previous Page 11 / 17 Next Page
Page Background

Medchem & Toxicology 2018

Page 42

Journal of Organic & Inorganic Chemistry

ISSN: 2472-1123

A n n u a l C o n g r e s s o n

Medicinal Chemistry,

Pharmacology and toxicology

J u l y 3 0 - 3 1 , 2 0 1 8

Am s t e r d a m , N e t h e r l a n d s

T

he metastatic disease significantly decreases the survival rate of patients

with head and neck squamous cell carcinoma (HNSCC). Src, a non-receptor

tyrosine kinase, plays critical roles in tumor progression and metastasis.

However, whether to effectively inhibit the function of Src in HNSCC remain

elusive.We

report, for thefirst time, blockadeof Srckinaseactivityby saracatinib

which effectively suppressed invasion and metastasis of HNSCC in preclinical

animal models. Mechanistic assessment of the drug effects in HNSCC cells

showed that saracatinib induced suppression of invasion/metastasis through

downregulating the expression levels of Vimentin and Snail proteins and

reversing Src-dependent epithelial-mesenchymal transition. In tests in mice,

saracatinib was loaded into the novel multifunctional nanoparticles exhibited

superior effects on suppression of HNSCC metastasis compared with free

drug, which is mainly attributed to highly specific and efficient tumor-targeted

drug delivery system. These findings and advances are of great importance to

the development of Src-targeted nanomedicine as a novel treatment modality

against HNSCC, especially for more extensive tumors.

Biography

Dr. Teng earned his Ph.D. from Sun Yat-sen University in

2007. He is an Assistant Professor in the Dept. of Oral Bio at

AU. He has authored more than 70 articles and chapters in

reputed journals and books and serves on the grant review

panels of CDMRP-PCRP-Ad-CET, NYUAD, and NFSC. He has

demonstrated an excellent commitment to serve the scientific

community through numerous editorial and reviewing activities.

yteng@augusta.edu

Blocking metastatic properties of head and neck cancer by

multifunctional nanoparticle-based saracatinib

Yong Teng

1,4,5

, Liwei Lang

1

, Chloe Shay

2

and Xuli Wang

3

1

Dental College of Georgia, Augusta University, Augusta, GA, USA

2

Emory Children’s Center, Emory University, Atlanta, GA, USA

3

University of Utah, Salt Lake City, UT, USA

4

Medical College of Georgia, Augusta University, Augusta, GA, USA

5

College of Allied Health, Augusta University, Augusta, GA, USA

Yong Teng et al., J Org Inorg Chem 2018, Volume 4

DOI: 10.21767/2472-1123-C3-008